DG

98.68

-0.26%↓

AD

32.29

-0.34%↓

BEI

125.85

-0.98%↓

RI

104.7

-0.19%↓

DG

98.68

-0.26%↓

AD

32.29

-0.34%↓

BEI

125.85

-0.98%↓

RI

104.7

-0.19%↓

DG

98.68

-0.26%↓

AD

32.29

-0.34%↓

BEI

125.85

-0.98%↓

RI

104.7

-0.19%↓

DG

98.68

-0.26%↓

AD

32.29

-0.34%↓

BEI

125.85

-0.98%↓

RI

104.7

-0.19%↓

DG

98.68

-0.26%↓

AD

32.29

-0.34%↓

BEI

125.85

-0.98%↓

RI

104.7

-0.19%↓

Search

Anheuser-Busch InBev SA/NV

Closed

Sector Consumer defensive

45.36 -0.81

Overview

Share price change

24h

Current

Min

44.89

Max

45.73

Key metrics

By Trading Economics

Income

599M

2.1B

Sales

-287M

15B

P/E

Sector Avg

15.822

36.003

EPS

0.98

Dividend yield

1.492

Profit margin

13.771

EBITDA

2B

5.4B

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+17.87 upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

1.49%

3.03%

Next Earnings

26 Feb 2025

Market Stats

By TradingEconomics

Market Cap

-4.6B

1.6T

Previous open

46.17

Previous close

45.36

News Sentiment

By Acuity

67%

33%

134 / 154 Consumer defensive

Anheuser-Busch InBev SA/NV Chart

Past performance is not a reliable indicator of future results.

Related News

3 Jan 2025, 14:04 UTC

Major Market Movers

Alcohol Stocks Fall After Surgeon General Warns on Cancer Links

31 Oct 2024, 23:43 UTC

Earnings

Bud Light Owner's U.S. Sales Bounce Back After Boycott -- 4th Update

31 Oct 2024, 12:25 UTC

Earnings

Bud Brewer AB InBev's Shares Fall After China Weakness Drags Sales -- 3rd Update

31 Oct 2024, 08:05 UTC

Earnings

Bud Brewer AB InBev's Sales Volumes Drop More Than Expected, Dragged by China Weakness -- 2nd Update

31 Oct 2024, 07:21 UTC

Earnings

Correction to AB InBev Article

31 Oct 2024, 06:54 UTC

Earnings

Bud Brewer AB InBev Misses Sales Expectations, Dragged by China Weakness -- Update

3 Jan 2025, 13:20 UTC

Top News

Update: Bud and Molson Stocks Fall as Surgeon General Issues Advisory on Alcohol's Link to Cancer -- Barrons.com

3 Jan 2025, 12:54 UTC

Top News

Bud and Molson Stocks Fall as Surgeon General Issues Advisory on Alcohol's Link to Cancer -- Barrons.com

9 Dec 2024, 10:33 UTC

Market Talk

European Beverage Stocks Likely to Outperform in 2025 -- Market Talk

8 Nov 2024, 19:43 UTC

Market Talk
Earnings

Molson Coors' Underperformance Partly Due to Volume Share Decline -- Market Talk

31 Oct 2024, 15:18 UTC

Earnings

Bud Light Boycott Eases but AB InBev Has a Fresh Problem -- Barrons.com

31 Oct 2024, 10:25 UTC

Earnings

Bud Light Boycott Eases But AB InBev Has Fresh Problem. Stock Falls After Earnings. -- Barrons.com

31 Oct 2024, 09:35 UTC

Market Talk
Earnings

AB InBev's Earnings Miss Looks Out of Character -- Market Talk

31 Oct 2024, 08:07 UTC

Market Talk
Earnings

AB InBev's Positive U.S. Performance Surprises Despite China Drag -- Market Talk

31 Oct 2024, 06:19 UTC

Earnings

Correct: AB InBev 3Q Net Pft $2.07B

31 Oct 2024, 06:19 UTC

Earnings

Correct: AB InBev 3Q Rev $15.05B

31 Oct 2024, 06:08 UTC

Earnings

AB InBev: Ebitda Lifted by Production Cost Efficiencies and Disciplined Overhead Management

31 Oct 2024, 06:07 UTC

Earnings

AB InBev: Overall Volume Performance Hit by Soft Consumer Environment in China and Argentina

31 Oct 2024, 06:06 UTC

Earnings

AB InBev: Revenue Supported by Management Initiatives and Ongoing Premiumization

31 Oct 2024, 06:05 UTC

Earnings

Analysts Saw AB InBev Net Pft at $1.92B

31 Oct 2024, 06:05 UTC

Earnings

AB InBev 3Q Net Pft $1.47B

31 Oct 2024, 06:05 UTC

Earnings

Analysts Saw AB InBev 3Q Rev $15.55B

31 Oct 2024, 06:05 UTC

Earnings

AB InBev 3Q Rev $15.57B

31 Oct 2024, 06:05 UTC

Earnings

AB InBev Had Seen 2024 Ebitda Growth Between 4%-8%

31 Oct 2024, 06:04 UTC

Earnings

AB InBev Sees 2024 Ebitda Growth Between 6%-8%

31 Oct 2024, 06:04 UTC

Earnings

AB InBev Narrows 2024 View

31 Oct 2024, 06:04 UTC

Earnings

AB InBev Launches $2B Share Buyback Program

31 Oct 2024, 06:03 UTC

Earnings

Analysts Saw AB InBev 3Q Adj EPS $0.92

31 Oct 2024, 06:03 UTC

Earnings

AB InBev 3Q Adj EPS $0.98

31 Oct 2024, 06:03 UTC

Earnings

AB InBev 3Q Adj Net Pft $1.97B

Peer Comparison

Price change

Anheuser-Busch InBev SA/NV Forecast

Price Target

By TipRanks

17.87% upside

12 Months Forecast

Average 61 EUR  17.87%

High 70 EUR

Low 50 EUR

Based on 13 Wall Street analysts offering 12 month price targets forAnheuser-Busch InBev SA/NV - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

13 ratings

8

Buy

2

Hold

3

Sell

Sentiment

By Acuity

134 / 154 Consumer defensive

News Sentiment

Bearish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Anheuser-Busch InBev SA/NV

Anheuser-Busch Inbev SA is a Belgium-based company. The Company is primarily engaged in the manufacturing of beer. The Company operates through seven segments: North America, Mexico, Latin America North, Latin America South, Europe, Asia Pacific, and Global Export and Holding Companies. The Company's brand portfolio includes global brands, such as Budweiser, Corona and Stella Artois; international brands, including Beck's, Leffe and Hoegaarden, and local champions, such as Bud Light, Skol, Brahma, Antarctica, Quilmes, Victoria, Modelo Especial, Michelob Ultra, Harbin, Sedrin, Klinskoye, Sibirskaya Korona, Chernigivske, Cass and Jupiler. The Company's soft drinks business consists of both own production and agreements with PepsiCo related to bottling and distribution arrangements between its various subsidiaries and PepsiCo. Ambev, which is a subsidiary of the Company, is a PepsiCo bottler. Brands that are distributed under these agreements are Pepsi, 7UP and Gatorade.